Analyst Expectations for Oscar Health's Future
Portfolio Pulse from Benzinga Insights
In the last quarter, Oscar Health (NYSE:OSCR) received mixed analyst ratings with 1 bullish, 1 somewhat bullish, and 2 indifferent. Over the past 3 months, 4 analysts have offered 12-month price targets for Oscar Health, with an average price target of $8.12, up by 27.27% from the previous average price target of $6.38.
November 02, 2023 | 3:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Oscar Health received mixed analyst ratings in the last quarter, with an average price target of $8.12, up by 27.27% from the previous average.
The mixed analyst ratings indicate uncertainty about the company's future performance. However, the increase in the average price target suggests that analysts are becoming more optimistic about the company's prospects, which could potentially have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100